<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01739881</url>
  </required_header>
  <id_info>
    <org_study_id>DSRB/2011/00380</org_study_id>
    <nct_id>NCT01739881</nct_id>
  </id_info>
  <brief_title>Evaluating the Pulmonary Nodule With Imaging and Biomarkers</brief_title>
  <official_title>Evaluating the Pulmonary Nodule With Imaging and Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National University Hospital, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National University Hospital, Singapore</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine if there are defining EBUS and confocal endoscopy features as
      well as exhaled alveolar gas VOC that can discriminate malignant pulmonary nodules or masses
      from benign etiology, thereby obviating unnecessary thoracotomy. Directly sampled alveolar
      gas VOC from patients with lung cancer will be compared against exhaled breath VOC for
      signature compounds that may complement CT in screening the population at risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AIMS

        1. To improve diagnostic yield of pulmonary nodule or mass by using combined approach of
           navigation bronchoscopy and EBUS.

        2. To determine if characteristic features of EBUS and confocal microendoscopy exist as
           well as VOC patterns in alveolar and exhaled gas that can aid in discriminating
           malignant pulmonary nodule or mass from benign etiology by correlating with pathology.

        3. To identify VOC patterns specific for lung cancer by correlating VOC from directly
           sampled alveolar gas and exhaled breath with pathology. Exhaled breath VOC signature may
           complement CT in screening population at risk.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2011</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlating pathology between EBUS, confocal microendoscopy and VOC patterns to aid in characterising malignant and benign etiology.</measure>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Olympus Ultrathin Bronchofibervideoscope (XP260F)</intervention_name>
    <description>The bronchovideoscope will be used together with an assisted image-guided bronchoscopic navigation software system called LungPoint®, to view lungs in a real time 3D manner.</description>
    <other_name>Olympus Lucera Broncho Fibervideoscope (BF-XP260F)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients aged above 21 years, capable of giving consent and suspected of lung
             cancer with radiological lung nodules and masses.

        Exclusion Criteria:

          -  Patients with contra-indications to bronchoscopy and CT-TTNA that include active
             myocardial ischemia, uncorrected coagulopathy, severe respiratory distress,
             uncontrollable cough, and pregnancy will be excluded. Before females in the
             reproductive age are recruited, urine pregnancy test will be performed and confirmed
             negative.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pyng Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National University Hospital, Singapore</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pyng Lee, MD</last_name>
    <phone>+65-67795555</phone>
    <email>mdclp@nus.edu.sg</email>
  </overall_contact>
  <location>
    <facility>
      <name>National University Hospital/ National University of Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pyng Lee, MD</last_name>
      <phone>+65-67795555</phone>
      <email>mdclp@nus.edu.sg</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7. Erratum in: CA Cancer J Clin. 2011 Mar-Apr;61(2):133-4.</citation>
    <PMID>20610543</PMID>
  </reference>
  <reference>
    <citation>Lee P, Colt HG. Bronchoscopy in lung cancer: appraisal of current technology and for the future. J Thorac Oncol. 2010 Aug;5(8):1290-300. doi: 10.1097/JTO.0b013e3181e41843. Review.</citation>
    <PMID>20661089</PMID>
  </reference>
  <reference>
    <citation>Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003 Jan;123(1 Suppl):115S-128S. Review.</citation>
    <PMID>12527571</PMID>
  </reference>
  <reference>
    <citation>Kurimoto N, Miyazawa T, Okimasa S, Maeda A, Oiwa H, Miyazu Y, Murayama M. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest. 2004 Sep;126(3):959-65.</citation>
    <PMID>15364779</PMID>
  </reference>
  <reference>
    <citation>Herth FJ, Ernst A, Becker HD. Endobronchial ultrasound-guided transbronchial lung biopsy in solitary pulmonary nodules and peripheral lesions. Eur Respir J. 2002 Oct;20(4):972-4.</citation>
    <PMID>12412691</PMID>
  </reference>
  <reference>
    <citation>Herth FJ, Eberhardt R, Becker HD, Ernst A. Endobronchial ultrasound-guided transbronchial lung biopsy in fluoroscopically invisible solitary pulmonary nodules: a prospective trial. Chest. 2006 Jan;129(1):147-50.</citation>
    <PMID>16424425</PMID>
  </reference>
  <reference>
    <citation>Eberhardt R, Kahn N, Gompelmann D, Schumann M, Heussel CP, Herth FJ. LungPoint--a new approach to peripheral lesions. J Thorac Oncol. 2010 Oct;5(10):1559-63. doi: 10.1097/JTO.0b013e3181e8b308.</citation>
    <PMID>20802352</PMID>
  </reference>
  <reference>
    <citation>Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK. PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):351-60.</citation>
    <PMID>12002710</PMID>
  </reference>
  <reference>
    <citation>Gildea TR, Mazzone PJ, Karnak D, Meziane M, Mehta AC. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med. 2006 Nov 1;174(9):982-9. Epub 2006 Jul 27.</citation>
    <PMID>16873767</PMID>
  </reference>
  <reference>
    <citation>Makris D, Scherpereel A, Leroy S, Bouchindhomme B, Faivre JB, Remy J, Ramon P, Marquette CH. Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions. Eur Respir J. 2007 Jun;29(6):1187-92. Epub 2007 Mar 14.</citation>
    <PMID>17360724</PMID>
  </reference>
  <reference>
    <citation>Eberhardt R, Anantham D, Ernst A, Feller-Kopman D, Herth F. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med. 2007 Jul 1;176(1):36-41. Epub 2007 Mar 22.</citation>
    <PMID>17379850</PMID>
  </reference>
  <reference>
    <citation>Horváth I, Lázár Z, Gyulai N, Kollai M, Losonczy G. Exhaled biomarkers in lung cancer. Eur Respir J. 2009 Jul;34(1):261-75. doi: 10.1183/09031936.00142508. Review.</citation>
    <PMID>19567608</PMID>
  </reference>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2012</study_first_submitted>
  <study_first_submitted_qc>November 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>November 28, 2012</last_update_submitted>
  <last_update_submitted_qc>November 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exhaled breath condensate (EBC) method</keyword>
  <keyword>Volatile Organic Compounds (VOCs)</keyword>
  <keyword>Endobronchial Ultrasound (EBUS)</keyword>
  <keyword>Confocal Endoscopy</keyword>
  <keyword>Exhaled alveolar gas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

